KYTX logo

KYTX
Kyverna Therapeutics Inc.

1,159
Mkt Cap
$679.95M
Volume
1.78M
52W High
$13.67
52W Low
$1.92
PE Ratio
-2.66
KYTX Fundamentals
Price
$9.71
Prev Close
$11.25
Open
$11.25
50D MA
$8.52
Beta
1.91
Avg. Volume
682,341.39
EPS (Annual)
-$3.64
P/B
2.52
Rev/Employee
$0.00
$165.82
Loading...
Loading...
News
all
press releases
Dow, Nasdaq, S&P 500 Futures Edge Higher After Trump Extends Iran Ceasefire: POET, NVTS, KYTX, TSLA Stocks Garner Focus Today
U.S. President Donald Trump said in a Truth Social post late Tuesday that he had extended the ceasefire with Iran, although adding that the military blockade in the Strait of Hormuz would continue.
Stocktwits·4h ago
News Placeholder
More News
News Placeholder
KYTX Stock Soars After Hours: What’s Driving The Rally?
Kyverna reported strong pivotal trial results for its one-time CAR-T therapy miv-cel, showing rapid mobility improvements and reversal of disability in patients with stiff person syndrome.
Stocktwits·5h ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Shares Down 7.2% - Should You Sell?
Kyverna Therapeutics (NASDAQ:KYTX) Trading Down 7.2% - What's Next...
MarketBeat·12h ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Trading 6.2% Higher - Should You Buy?
Kyverna Therapeutics (NASDAQ:KYTX) Shares Up 6.2% - Still a Buy...
MarketBeat·1d ago
News Placeholder
Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives Average Recommendation of "Moderate Buy" from Analysts
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the five analysts that are currently covering the stock, Marketbeat reports...
MarketBeat·11d ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Shares Down 6.7% - Here's What Happened
Kyverna Therapeutics (NASDAQ:KYTX) Trading Down 6.7% - What's Next...
MarketBeat·11d ago
News Placeholder
HC Wainwright Analysts Increase Earnings Estimates for KYTX
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for Kyverna Therapeutics in a research report issued to clients and...
MarketBeat·21d ago
News Placeholder
Brokers Issue Forecasts for KYTX FY2027 Earnings
Kyverna Therapeutics, Inc. (NASDAQ:KYTX - Free Report) - Stock analysts at HC Wainwright issued their FY2027 EPS estimates for shares of Kyverna Therapeutics in a research note issued on Monday, March 30th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings per share of...
MarketBeat·22d ago
News Placeholder
Kyverna Therapeutics (NASDAQ:KYTX) Announces Earnings Results
Kyverna Therapeutics (NASDAQ:KYTX - Get Free Report) posted its earnings results on Thursday. The company reported ($0.80) earnings per share (EPS) for the quarter, meeting the consensus estimate of...
MarketBeat·26d ago
News Placeholder
Kyverna Therapeutics (KYTX) Expected to Announce Quarterly Earnings on Wednesday
Kyverna Therapeutics (NASDAQ:KYTX) will be releasing its Q4 2025 earnings before the market opens on Wednesday, April 1. (View Earnings Report at...
MarketBeat·28d ago
<
1
2
...
>

Latest KYTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.